KPV (Lys-Pro-Val) is a C-terminal tripeptide fragment of alpha-Melanocyte Stimulating Hormone (alpha-MSH), studied for its role in NF-kB inflammatory signaling pathway inhibition across multiple tissue research models. Published research has characterized KPV's mechanism as cellular-level interruption of NF-kB activation — the central regulator of inflammatory gene expression. This pathway-specific mechanism has been studied in gastrointestinal tissue models, including IBD-related tissue research, dermal wound healing models, and skin barrier research. Research has examined KPV's interaction with inflammatory signaling cascades through direct nuclear pathway modulation rather than systemic immune pathway suppression. This specificity profile has attracted interest in inflammatory signaling research. Studies have examined KPV across gut inflammation models, intestinal epithelial cell research, dermal healing models, and skin barrier function studies. The compound's small size as a tripeptide contributes to its cellular penetration properties documented in published research. For researchers studying NF-kB signaling, gastrointestinal inflammation mechanisms, or dermal repair biology, KPV represents a well-characterized tripeptide with a specific documented mechanism in the published literature. For research use only.
Batch documentation ships with every order. To match your vial's lot number, request the current lot COA from the product page.